O-I GLASS, INC. /DE/, 10-Q filed on 4/29/2026
Quarterly Report
v3.26.1
Document and Entity Information
3 Months Ended
Mar. 31, 2026
shares
Cover  
Document Type 10-Q
Document Quarterly Report true
Document Period End Date Mar. 31, 2026
Document Transition Report false
Securities Act File Number 1-9576
Entity Registrant Name O-I GLASS, INC.
Entity Incorporation, State or Country Code DE
Entity Tax Identification Number 22-2781933
Entity Address, Address Line One One Michael Owens Way
Entity Address, City or Town Perrysburg
Entity Address, State or Province OH
Entity Address, Postal Zip Code 43551
City Area Code 567
Local Phone Number 336-5000
Title of 12(b) Security Common Stock, par value $.01 per share
Security Exchange Name NYSE
Trading Symbol OI
Entity Current Reporting Status Yes
Entity Interactive Data Current Yes
Entity Filer Category Large Accelerated Filer
Entity Small Business false
Entity Emerging Growth Company false
Entity Shell Company false
Entity Common Stock, Shares Outstanding 153,299,563
Entity Central Index Key 0000812074
Amendment Flag false
Document Fiscal Year Focus 2026
Current Fiscal Year End Date --12-31
Document Fiscal Period Focus Q1
v3.26.1
CONSOLIDATED RESULTS OF OPERATIONS - USD ($)
shares in Thousands, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CONSOLIDATED RESULTS OF OPERATIONS    
Net sales $ 1,540 $ 1,567
Revenue, Product and Service [Extensible Enumeration] us-gaap:ProductMember us-gaap:ProductMember
Cost of goods sold $ (1,341) $ (1,287)
Gross profit 199 280
Selling and administrative expense (99) (109)
Research, development and engineering expense (9) (13)
Interest expense, net (79) (81)
Equity earnings 26 23
Other expense, net (91) (82)
Earnings (loss) before income taxes (53) 18
Provision for income taxes (18) (30)
Net loss (71) (12)
Net earnings attributable to noncontrolling interests (2) (4)
Net loss attributable to the Company $ (73) $ (16)
Basic earnings (loss) per share:    
Net loss attributable to the Company (in dollars per share) $ (0.48) $ (0.1)
Weighted average shares outstanding (thousands) (in shares) 152,683 153,708
Diluted earnings (loss) per share:    
Net loss attributable to the Company (in dollars per share) $ (0.48) $ (0.1)
Weighted average diluted shares outstanding (thousands) (in shares) 152,683 153,708
v3.26.1
CONSOLIDATED COMPREHENSIVE INCOME (LOSS) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
CONSOLIDATED COMPREHENSIVE INCOME (LOSS)    
Net loss $ (71) $ (12)
Other comprehensive income (loss):    
Foreign currency translation adjustments 23 97
Pension and other postretirement benefit adjustments, net of tax 8 (3)
Change in fair value of derivative instruments, net of tax 34 (28)
Other comprehensive income 65 66
Total comprehensive income (loss) (6) 54
Comprehensive income attributable to noncontrolling interests (5) (9)
Comprehensive income (loss) attributable to the Company $ (11) $ 45
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Current assets:      
Cash and cash equivalents $ 317 $ 759 $ 424
Trade receivables, net of allowance of $32 million, $31 million, and $32 million at March 31, 2026, December 31, 2025 and March 31, 2025 805 601 758
Inventories 1,003 1,002 985
Prepaid expenses and other current assets 259 239 224
Total current assets 2,384 2,601 2,391
Property, plant and equipment, net 3,420 3,447 3,381
Goodwill 1,469 1,487 1,365
Intangibles, net 181 188 193
Other assets 1,496 1,520 1,399
Total assets 8,950 9,243 8,729
Current liabilities:      
Accounts payable 1,057 1,201 1,026
Short-term loans and long-term debt due within one year 160 162 226
Other liabilities 677 726 679
Total current liabilities 1,894 2,089 1,931
Long-term debt 4,800 4,837 4,786
Other long-term liabilities 824 872 763
Share owners' equity 1,432 1,445 1,249
Total liabilities and share owners' equity $ 8,950 $ 9,243 $ 8,729
v3.26.1
CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
CONSOLIDATED BALANCE SHEETS      
Trade receivables allowance $ 32 $ 31 $ 32
v3.26.1
CONSOLIDATED CASH FLOWS - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (71) $ (12)
Non-cash charges (credits):    
Depreciation and amortization 119 118
Pension expense 9 7
Stock-based compensation expense 5 4
Restructuring, asset impairment and related charges 38 82
Legacy environmental charge   4
(Gain) loss on sale of joint venture and miscellaneous assets 46 (6)
Pension contributions (10) (7)
Cash paid for restructuring activities (35) (28)
Change in components of working capital (376) (314)
Other, net (a) (19) (19)
Cash utilitzed in operating activities (294) (171)
Investing activities:    
Cash payments for property, plant and equipment (142) (135)
Net cash proceeds on sale of joint venture and miscellaneous assets 5 13
Net cash proceeds (payments) for hedging activity (2) 2
Cash utilized in investing activities (139) (120)
Financing activities:    
Additions to long-term debt 23 362
Repayments of long-term debt (27) (387)
Increase (decrease) in short-term loans (1) 9
Shares repurchased (10) (10)
Other, net (b) (4) (7)
Cash utilized in financing activities (19) (33)
Effect of exchange rate fluctuations on cash 10 14
Change in cash (442) (310)
Cash at beginning of period 759 734
Cash at end of period $ 317 $ 424
v3.26.1
Segment Information
3 Months Ended
Mar. 31, 2026
Segment Information  
Segment Information

1. Segment Information

The Company has two reportable segments and two operating segments based on its geographic locations: the Americas and Europe. These two segments are aligned with the Company’s internal approach to managing, reporting, and evaluating performance of its global glass operations. Certain assets and activities not directly related to one of the segments or to glass manufacturing are reported within Retained corporate costs and other. These include licensing, equipment manufacturing, global engineering, certain equity investments and certain minor businesses in the Asia Pacific region. Retained corporate costs and other also includes certain headquarters administrative and facilities costs and certain incentive compensation and other benefit plan costs that are global in nature and are not allocable to the reportable segments.

The Company’s measure of profit for its reportable segments is segment operating profit, which is a non-GAAP financial measure that consists of consolidated earnings before interest income, interest expense, and provision for income taxes and excludes amounts related to certain items that management considers not representative of ongoing operations and other adjustments, as well as certain retained corporate costs. The Company’s management, including the chief operating decision maker (defined as the Chief Executive Officer), uses segment operating profit, supplemented by net sales and selected cash flow information, to evaluate segment performance and allocate resources. Segment operating profit for reportable segments includes an allocation of some corporate expenses based on both a percentage of sales and direct billings based on the costs of specific services provided. Segment operating profit is not a recognized term under accounting principles generally accepted in the United States (“U.S. GAAP”) and, therefore, does not purport to be an alternative to earnings (loss) before income taxes. Further, the Company’s measure of segment operating profit may not be comparable to similarly titled measures used by other companies.

In accordance with ASU 2023-07, “Segment Reporting (Topic 280): Improvements to Reportable Segment Disclosures,” the Company has disclosed significant segment expenses reviewed by its chief operating decision maker. Other segment expenses (income) includes intangible amortization expense (Americas only), foreign currency exchange gains or losses, certain overhead expenses and other gains or losses.

Financial information for the three months ended March 31, 2026 and 2025 regarding the Company’s reportable segments is as follows, as well as a reconciliation of segment operating profit to earnings (loss) before income taxes:

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Americas

Europe

Total

Americas

Europe

Total

Reportable segment net sales

$

871

$

655

$

1,526

$

873

$

667

$

1,540

Other

14

27

Net Sales

 

 

$

1,540

$

1,567

Less:

Cost of goods sold

706

622

703

558

Selling, administrative, engineering and research and development expenses

36

39

43

46

Equity earnings

(20)

(6)

(19)

(4)

Other segment expenses (income)

7

5

(1)

Segment operating profit

$

142

$

$

142

$

141

$

68

$

209

Items excluded from segment operating profit:

Reconciliation of segment operating profit

Retained corporate costs and other

(32)

(30)

Restructuring, asset impairment and other charges

(38)

(82)

Legacy environmental charge

(4)

Gain (loss) on sale of joint venture and miscellaneous assets

(46)

6

Interest expense, net

(79)

(81)

Earnings (loss) before income taxes

$

(53)

$

18

As of March 31,

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Reportable

  ​ ​ ​

Retained

  ​ ​ ​

Consoli-

 

Segment

Corp Costs

dated

 

Americas

Europe

Totals

and Other

Totals

 

Total assets:

2026

$

4,757

$

3,873

$

8,630

$

320

$

8,950

2025

4,707

3,682

8,389

340

8,729

Equity investments:

2026

$

474

$

213

$

687

$

33

$

720

2025

456

193

649

34

683

Three months ended March 31,

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Reportable

  ​ ​ ​

Retained

  ​ ​ ​

Consoli-

Segment

Corp Costs

dated

Americas

Europe

Totals

and Other

Totals

Equity earnings:

2026

$

20

$

6

$

26

$

$

26

2025

19

4

23

23

Capital expenditures:

2026

$

65

$

76

$

141

$

1

$

142

2025

62

72

134

1

135

Depreciation and amortization expense:

2026

$

71

$

42

$

113

$

3

$

116

2025

73

37

110

5

115

The Company’s tangible long-lived assets, including property, plant and equipment and operating lease right-of-use assets, by geographic region are as follows:

As of March 31,

  ​ ​ ​

U.S.

  ​ ​ ​

Non-U.S.

  ​ ​ ​

Total

 

2026

$

774

$

2,829

$

3,603

2025

 

897

2,689

3,586

The Company’s net sales by geographic region are as follows:

Three months ended March 31,

  ​ ​ ​

U.S.

  ​ ​ ​

Non-U.S.

  ​ ​ ​

Total

 

2026

$

407

$

1,133

$

1,540

2025

 

441

1,126

1,567

Operations outside the U.S. that accounted for 10% or more of consolidated net sales during the three months ended March 31, 2026 and 2025 were in France (2026-12%, 2025-14%), Italy (2026-12%, 2025-12%), and Mexico (2026-13%, 2025-13%).

v3.26.1
Revenue
3 Months Ended
Mar. 31, 2026
Revenue  
Revenue

2. Revenue

Revenue is recognized at a point in time when obligations under the terms of the Company’s contracts and related purchase orders with its customers are satisfied. This occurs with the transfer of control of glass containers, which primarily takes place when products are shipped from the Company’s manufacturing or warehousing facilities to the customer. Revenue is measured as the amount of consideration the Company expects to receive in exchange for transferring goods, which includes estimated provisions for rebates, discounts, returns and allowances. Amounts billed to customers related to shipping and handling or other pass-through items are included in net sales in the Condensed Consolidated Results of Operations. Sales, value-added, and other taxes the Company collects concurrent with revenue-producing activities are excluded from revenue. The Company’s payment terms are based on customary business practices and can vary by customer type. The term between invoicing and when payment is due is not significant. Also, the Company elected to account for shipping and handling costs as a fulfillment cost at the time of shipment.

For the three-month periods ended March 31, 2026 and 2025, the Company had no material bad debt expense, and there were no material contract assets, contract liabilities or deferred contract costs recorded in the Condensed Consolidated Balance Sheets. For the three-month periods ended March 31, 2026 and 2025, revenue recognized from prior periods was not material.

The following tables for the three months ended March 31, 2026 and 2025 disaggregate the Company’s revenue by customer end use:

Three months ended March 31, 2026

  ​ ​ ​

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

465

 

$

464

 

$

929

Food and other

 

239

118

 

357

Non-alcoholic beverages

 

167

73

 

240

Reportable segment totals

$

871

$

655

$

1,526

Other

 

14

Net sales

 

$

1,540

Three months ended March 31, 2025

  ​ ​ ​

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

503

$

481

$

984

Food and other

 

217

111

 

328

Non-alcoholic beverages

 

153

75

 

228

Reportable segment totals

$

873

$

667

$

1,540

Other

 

27

Net sales

 

$

1,567

v3.26.1
Credit Losses
3 Months Ended
Mar. 31, 2026
Credit Losses  
Credit Losses

3. Credit Losses

The Company is exposed to credit losses primarily through its sales of glass containers to customers. The Company’s trade receivables from customers are due within one year or less. The Company assesses each customer’s ability to pay for the glass containers it sells to them by conducting a credit review. The credit review considers the expected billing exposure and timing for payment and the customer’s established credit rating or the Company’s assessment of the customer’s creditworthiness, based on an analysis of their financial statements when a credit rating is not available. The Company also considers contract terms and conditions, country and political risk, and business strategy in its evaluation. A credit limit is established for each customer based on the outcome of this review. The Company may require collateralized asset support or a prepayment to mitigate credit risk. The Company monitors its ongoing credit exposure through the active review of customer balances against contract terms and due dates, including timely account reconciliation, dispute resolution and payment confirmation. The Company may employ collection agencies and legal counsel to pursue the recovery of defaulted receivables.

At March 31, 2026 and 2025, the Company reported $805 million and $758 million of accounts receivable, respectively, net of allowances of $32 million and $32 million, respectively. Changes in the allowance were not material for each of the three months ended March 31, 2026 and 2025.

v3.26.1
Inventories
3 Months Ended
Mar. 31, 2026
Inventories  
Inventories

4. Inventories

Major classes of inventory at March 31, 2026, December 31, 2025 and March 31, 2025 are as follows:

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Finished goods

$

805

$

781

$

747

Raw materials

 

157

 

182

 

188

Operating supplies

 

41

 

39

 

50

$

1,003

$

1,002

$

985

v3.26.1
Derivative Instruments
3 Months Ended
Mar. 31, 2026
Derivative Instruments  
Derivative Instruments

5. Derivative Instruments

The Company has certain derivative assets and liabilities which consist of natural gas forwards and collars, foreign exchange option and forward contracts, interest rate swaps and cross-currency swaps. The valuation of these instruments is determined primarily using the income approach, including discounted cash flow analysis on the expected cash flows of each derivative. Natural gas prices, foreign exchange rates and interest rates are the significant inputs into the valuation models. The Company also evaluates counterparty risk in determining fair values. This analysis reflects the contractual terms of the derivatives, including the period to maturity, and uses observable market-based inputs, including interest rate curves and implied volatilities. Estimates of the fair value of foreign currency and commodity derivative instruments are determined using exchange traded prices and rates. The fair values of interest rate swaps are determined using the market standard methodology of netting the discounted future fixed cash receipts (or payments) and the discounted expected variable cash payments (or receipts). The variable cash payments (or receipts) are based on an expectation of future interest rates (forward curves) derived from observable market interest rate curves. These inputs

are observable in active markets over the terms of the instruments the Company holds, and accordingly, the Company classifies its derivative assets and liabilities as Level 2 in the hierarchy.

Commodity Forward Contracts and Collars Designated as Cash Flow Hedges

The Company has entered into commodity forward contracts and collars related to forecasted natural gas requirements, the objective of which are to limit the effects of fluctuations in future market prices of natural gas and the related volatility in cash flows.

An unrecognized loss of $7 million and $0 at March 31, 2026 and December 31, 2025, respectively, and an unrecognized gain of $1 million at March 31, 2025 related to the commodity forward contracts and collars was included in Accumulated other comprehensive income (loss) (“Accumulated OCI”), and will be reclassified into earnings over the next 12 months.

Cash Flow Hedges of Foreign Exchange Risk

The Company has variable-interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency. The Company uses derivatives to manage these exposures and designates these derivatives as cash flow hedges of foreign exchange risk.

No unrecognized gains related to cross-currency swaps were included in Accumulated OCI at March 31, 2026, December 31, 2025 and March 31, 2025.

Fair Value Hedges of Foreign Exchange Risk

The Company has fixed and variable interest rate borrowings denominated in currencies other than the functional currency of the borrowing subsidiaries. As a result, the Company is exposed to fluctuations in the currency of the borrowing against the subsidiaries’ functional currency.  The Company uses derivatives to manage these exposures and designates these derivatives as fair value hedges of foreign exchange risk. Approximately $5 million, $1 million and $2 million of the components were excluded from the assessment of effectiveness and are included in Accumulated OCI at March 31, 2026, December 31, 2025 and March 31, 2025, respectively.

Net Investment Hedges

The Company is exposed to fluctuations in foreign exchange rates on investments it holds in non-U.S. subsidiaries and uses cross-currency swaps to partially hedge this exposure.

Foreign Exchange Derivative Contracts Not Designated as Hedging Instruments

The Company uses short-term forward exchange or option agreements to purchase foreign currencies at set rates in the future. These agreements are used to limit exposure to fluctuations in foreign currency exchange rates for significant planned purchases of fixed assets or commodities that are denominated in currencies other than the subsidiaries’ functional currency. The Company also uses foreign exchange agreements to offset the foreign currency exchange rate risk for receivables and payables, including intercompany receivables, payables, and loans, not denominated in, or indexed to, their functional currencies.

Balance Sheet Classification

The following table shows the amount and classification (as noted above) of the Company’s derivatives at March 31, 2026, December 31, 2025 and March 31, 2025:

Fair Value of

Fair Value of

Hedge Assets

Hedge Liabilities

March 31,

December 31,

March 31,

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Derivatives designated as hedging instruments:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Commodity forward contracts and collars (a)

$

19

$

$

1

$

2

$

2

$

2

Fair value hedges of foreign exchange risk (b)

2

1

3

64

78

90

Net investment hedges (c)

11

11

11

174

207

73

Total derivatives accounted for as hedges

$

32

$

12

$

15

$

240

$

287

$

165

Derivatives not designated as hedges:

Foreign exchange derivative contracts (d)

5

2

10

6

13

Total derivatives

$

37

$

14

$

25

$

246

$

287

$

178

Current

$

22

$

14

$

25

$

67

$

71

$

60

Noncurrent

15

-

179

216

118

Total derivatives

$

37

$

14

$

25

$

246

$

287

$

178

(a)The notional amount of the commodity forward contracts and collars was approximately 25 million, 9 million, and 8 million British Thermal Units at March 31, 2026, December 31, 2025, and March 31, 2025, respectively. The maximum maturity dates are in 2027 at March 31, 2026, December 31, 2025, and March 31, 2025.
(b)The notional amounts of the fair value hedges of foreign exchange risk were $400 million at March 31, 2026, $400 million at December 31, 2025 and $816 million at March 31, 2025. The maximum maturity dates are in 2030 at March 31, 2026, December 31, 2025 and March 31, 2025.
(c)The notional amounts of the net investment hedges were €1,176 million at March 31, 2026, €1,176 million at December 31, 2025 and €969 million at March 31, 2025. The maximum maturity dates are in 2028 at March 31, 2026 and December 31, 2025 and in 2026 at March 31, 2025.
(d)The notional amounts of the foreign exchange derivative contracts were $677 million, $526 million and $957 million at March 31, 2026, December 31, 2025 and March 31, 2025, respectively. The maximum maturity dates are in 2026 at March 31, 2026 and December 31, 2025 and at March 31, 2025.

Gain (Loss) Recognized in OCI (Effective Portion)

Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) (1)

Three months ended March 31

Three months ended March 31,

Derivatives designated as hedging instruments:

 

2026

2025

2026

2025

Cash Flow Hedges

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Commodity forward contracts and collars (a)

$

(1)

$

6

$

$

Net Investment Hedges

Net Investment Hedges (b)

36

(37)

3

3

$

35

$

(31)

$

3

$

3

Amount of Gain (Loss) Recognized in Other expense, net

Three months ended March 31,

Derivatives not designated as hedges:

 

2026

2025

Foreign exchange derivative contracts

  ​ ​ ​

$

(4)

  ​ ​ ​

$

5

  ​ ​ ​

(1) Gains and losses reclassified from Accumulated OCI and recognized in income are recorded to (a) cost of goods sold or (b) interest expense, net.

v3.26.1
Restructuring Accruals
3 Months Ended
Mar. 31, 2026
Restructuring Accruals  
Restructuring Accruals

6. Restructuring Accruals

Selected information related to the restructuring accruals for the three months ended March 31, 2026 and 2025 is as follows:

Fit to Win program

Employee

Asset

Other

Total

  ​ ​ ​

Costs

Impairment

Exit Costs

  ​ ​ ​

Restructuring

Balance at January 1, 2026

$

113

$

$

70

$

183

Charges

27

11

38

Net cash paid, principally severance and related benefits

 

(25)

(10)

 

(35)

Other, including foreign exchange translation

 

(2)

(3)

 

(5)

Balance at March 31, 2026

$

113

$

$

68

$

181

Fit to Win program

Other Restructuring

Employee

Asset

Other

Employee

Asset

Other

Total

Costs

Impairment

Exit Costs

Costs

Impairment

Exit Costs

Restructuring

Balance at January 1, 2025

$

51

$

$

18

$

7

$

$

4

$

80

Charges

50

14

18

82

Write-down of assets to net realizable value

(14)

(14)

Net cash paid, principally severance and related benefits

 

(23)

(4)

 

(1)

 

(28)

Balance at March 31, 2025

$

78

$

$

32

$

6

$

$

4

$

120

When a decision is made to take restructuring actions, the Company manages and accounts for them programmatically apart from the ongoing operations of the business. Information related to major programs is presented separately, while minor initiatives are presented on a combined basis.

As of March 31, 2026, the Company’s only major restructuring program was the Fit to Win initiative, which is expected to reduce redundant production capacity and begin to optimize the network, as well as streamline other cost areas, such as selling, general and administrative expenses.  Details regarding charges, payments and other changes to the Fit to Win restructuring accruals are presented in the tables above. The Fit to Win initiative is expected to last at

least through 2026, but management does not yet have an estimate for the total restructuring charges to be incurred with this program.

For the three months ended March 31, 2026, the Company recorded restructuring, asset impairment and other charges of approximately $38 million to Other expense, net in the Condensed Consolidated Results of Operations, all of which related to the Fit to Win program. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($3 million), Europe segment ($31 million) and Retained corporate costs and other ($4 million). As of March 31, 2026, the Company has incurred cumulative charges of approximately $684 million related to the Fit to Win program. Additional restructuring charges are expected in future quarters when management completes its assessment to reduce redundant production capacity and streamline costs. The Company expects that the majority of the remaining cash expenditures related to the accrued employee and other exit costs will be paid out over the next several years.

For the three months ended March 31, 2025, the Company recorded restructuring, asset impairment and other charges of approximately $82 million to Other expense, net in the Condensed Consolidated Results of Operations, all of which related to the Fit to Win program. These charges consisted of employee costs, such as severance and benefit-related costs, write-down of assets and other exit costs in the Americas segment ($6 million), Europe segment ($52 million) and Retained corporate costs and other ($24 million). As of March 31, 2025, the Company had incurred cumulative charges of approximately $283 million related to the Fit to Win program.

The Company’s decisions to curtail selected production capacity have resulted in write-downs of certain long-lived assets to the extent their carrying value exceeded fair value or fair value less cost to sell. The Company classified the significant assumptions used to determine the fair value of the impaired assets in the period that the measurement was taken as Level 3 (third-party appraisals, where applicable) in the fair value hierarchy as set forth in the general accounting principles for fair value measurements. For the asset impairments recorded during the three-months ended March 31, 2026, the remaining carrying value of the impaired assets was approximately $0.

v3.26.1
Pension Benefit Plans
3 Months Ended
Mar. 31, 2026
Pension Benefit Plans  
Pension Benefit Plans

7. Pension Benefit Plans

The components of the net periodic pension cost for the three months ended March 31, 2026 and 2025 are as follows:

U.S.

Non-U.S.

 

Three months ended March 31,

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Service cost

$

1

$

1

$

2

$

2

Interest cost

 

10

 

11

 

9

 

9

Expected asset return

(12)

(13)

(7)

(8)

Amortization of actuarial loss

3

3

3

2

Net periodic pension cost

$

2

$

2

$

7

$

5

The components of pension expense, other than the service cost component, are included in Other expense, net in the Condensed Consolidated Results of Operations.

v3.26.1
Income Taxes
3 Months Ended
Mar. 31, 2026
Income Taxes.  
Income Taxes

8. Income Taxes

The Company calculates its interim tax provision using the estimated annual effective tax rate (“EAETR”) methodology in accordance with ASC 740-270. The EAETR is applied to the year-to-date ordinary income, exclusive of discrete items. The tax effects of discrete items are then included to arrive at the total reported interim tax provision. The determination of the EAETR is based upon a number of estimates, including the estimated annual pretax ordinary income or loss in each tax jurisdiction in which the Company operates. The tax effects of discrete items are recognized in the tax provision in the quarter they occur, in accordance with U.S. GAAP. Depending on various factors, such as the item’s significance in relation to total income and the rate of tax applicable in the jurisdiction to which it relates, discrete items in any quarter can materially impact the reported effective tax rate. The Company’s annual effective tax rate may be affected by the mix of earnings in the U.S. and foreign jurisdictions, and factors such as changes in tax laws, tax rates

or regulations, changes in business, changing interpretation of existing tax laws or regulations and the finalization of tax audits and reviews, as well as other factors. As such, there can be significant volatility in interim tax provisions. The annual effective tax rate differs from the statutory U.S. Federal tax rate of 21%, primarily because of varying non-U.S. tax rates and the impact of the U.S. valuation allowance.

The Company is currently under income tax examination in various tax jurisdictions in which it operates, including Brazil, Canada, Colombia, Italy, Peru, Poland and the U.S. The years under examination range from 2004 through 2023. The Company has received tax assessments in excess of established reserves. The Company is contesting these tax assessments, and will continue to do so, including pursuing all available remedies, such as appeals and litigation, if necessary. The Company believes that adequate provisions for all income tax uncertainties have been made. However, if tax assessments are settled against the Company at amounts in excess of established reserves, it could have a material impact on the Company’s consolidated results of operations, financial position or cash flows. Due to uncertainties regarding the ultimate resolution of income tax examinations, the Company is not able to reasonably estimate any tax assessments that may be settled at amounts in excess of established reserves in future periods, or the future periods in which any income tax payments to settle these provisions for income tax uncertainties.

v3.26.1
Debt
3 Months Ended
Mar. 31, 2026
Debt  
Debt

9. Debt

The following table summarizes the long-term debt of the Company at March 31, 2026, December 31, 2025, and March 31, 2025:

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Secured Credit Agreement:

Revolving Credit Facility:

Revolving Loans

$

$

$

Term Loans:

Term Loans A

792

799

Term Loans B

642

643

Previous Secured Credit Agreement:

Revolving Credit Facility:

Revolving Loans

185

Term Loans:

Term Loans A

1,338

Senior Notes:

6.625%, due 2027

611

610

609

6.250%, due 2028 (€600 million)

684

700

645

5.250%, due 2029 (€500 million)

568

581

535

4.750%, due 2030

398

397

397

7.250%, due 2031

684

684

683

7.375%, due 2032

297

297

296

Finance leases

161

174

192

Other

 

27

18

9

Total long-term debt

 

4,864

 

4,903

4,889

Less amounts due within one year

 

64

66

103

Long-term debt

$

4,800

$

4,837

$

4,786

The Company presents debt issuance costs in the Condensed Consolidated Balance Sheets as a deduction of the carrying amount of the related debt liability.

On September 30, 2025, certain of the Company’s subsidiaries entered into an Amended and Restated Credit Agreement and Syndicated Facility Agreement (the “Credit Agreement”), which refinanced in full the previous credit agreement. The Credit Agreement provides for up to $2.7 billion of borrowings pursuant to term loans A, term loans B and a revolving credit facility. The term loans A mature, and the revolving credit facility terminates, in September 2030, and the term loans B mature in September 2032; provided, however, that if any of the senior notes issued by certain subsidiaries of the Company are outstanding on the date that is 91 days prior to the maturity date for such senior notes (any such date, a “Springing Maturity Date”), then the term loans A, the revolving credit facility and the term loans B will mature and terminate, as applicable, on such Springing Maturity Date. Borrowings under the Credit Agreement are secured by certain collateral of the Company and certain of its subsidiaries.

At March 31, 2026, the Credit Agreement includes a $1.25 billion multicurrency revolving credit facility, the U.S. dollar equivalent of $800 million in term loan A facilities ($792 million outstanding balance at March 31, 2026, net of debt issuance costs) and $650 million in term loan B facilities ($642 million outstanding balance at March 31, 2026, net of debt issuance costs). At March 31, 2026, the Company’s subsidiaries that are party to the Credit Agreement had unused credit of $1.24 billion available under the revolving credit facilities as part of the Credit Agreement. The weighted average interest rate on borrowings outstanding under the Credit Agreement at March 31, 2026 was 5.36%.

The Credit Agreement contains various covenants that restrict, among other things and subject to certain exceptions, the ability of the Company to incur certain indebtedness and liens, make certain investments, become liable under contingent obligations in certain defined instances only, make restricted payments, make certain asset sales within guidelines and limits, engage in certain affiliate transactions, participate in sale and leaseback financing arrangements, alter its fundamental business, and amend certain subordinated debt obligations.

The Credit Agreement also contains one financial maintenance covenant, a Secured Leverage Ratio, for the benefit of lenders under the term loans A and the revolving credit facility (and, following an acceleration of the term loans A and the revolving credit facility, for the benefit of the lenders under the term loans B) that requires the Company and certain of its subsidiaries, collectively, not to exceed a ratio of 2.50x calculated by dividing consolidated Net Indebtedness that is then secured by Liens on property or assets of the Company and certain of its subsidiaries by Consolidated EBITDA, as each such capitalized term is defined in the Credit Agreement. The Secured Leverage Ratio could restrict the ability of the Company and certain of its subsidiaries to undertake additional financing or acquisitions to the extent that such financing or acquisitions would cause the Secured Leverage Ratio to exceed the specified maximum.

Failure to comply with these covenants and restrictions could result in an event of default under the Credit Agreement. In such an event, the applicable borrowers under the Credit Agreement would not be able to request borrowings under the revolving credit facility, and all amounts outstanding under the Credit Agreement, together with accrued interest, could then be declared immediately due and payable. Upon the occurrence and for the duration of a payment event of default, an additional default interest rate equal to 2.0% per annum will apply to all overdue obligations under the Credit Agreement.  If an event of default occurs under the Credit Agreement and the lenders cause all of the outstanding debt obligations under the Credit Agreement to become due and payable, this could result in a default under a number of other outstanding debt securities and could lead to an acceleration of obligations related to these debt securities.  As of March 31, 2026, the Company was in compliance with all covenants and restrictions in the Credit Agreement.  In addition, the Company believes that it will remain in compliance for the term of the Credit Agreement and that its ability to borrow additional funds under the Credit Agreement will not be adversely affected by the covenants and restrictions.

The Total Leverage Ratio (as defined in the Credit Agreement) determines pricing under the Credit Agreement for the Term Loans A and the revolving credit facility. The interest rate on borrowings under the Credit Agreement is, at the option of the applicable borrower, the Base Rate, Term SOFR or, for non-U.S. Dollar borrowings only, the Eurocurrency Rate (each such capitalized term as defined in the Credit Agreement), plus an applicable margin. The applicable margin, for the Term Loans A and the revolving credit facility, ranges from 1.00% to 1.75% for Term SOFR loans and Eurocurrency Rate loans and from 0.00% to 0.75% for Base Rate loans. The applicable margin, for the Term Loans B, is 3.00% for Term SOFR loans. In addition, a commitment fee is payable on the unused revolving credit facility commitments ranging from 0.20% to 0.35% per annum, depending on the Total Leverage Ratio.

Obligations under the Credit Agreement are secured by substantially all of the assets, excluding real estate and certain other excluded assets, of certain of the Company’s domestic subsidiaries and certain foreign subsidiaries. Such obligations are also secured by a pledge of intercompany debt and equity investments in certain of the Company’s domestic subsidiaries and, in the case of foreign obligations, of stock of certain foreign subsidiaries. All obligations under the Credit Agreement are guaranteed by certain domestic subsidiaries of the Company, and certain foreign obligations under the Credit Agreement are guaranteed by certain foreign subsidiaries of the Company.

The Company assesses its capital raising and refinancing needs on an ongoing basis and may enter into additional credit facilities and seek to issue equity and/or debt securities in the domestic and international capital markets if market conditions are favorable. Also, depending on market conditions, the Company may elect to repurchase portions of its debt securities in the open market.

The carrying amounts reported for certain long-term debt obligations subject to frequently redetermined interest rates approximate fair value. Fair values for the Company’s significant fixed rate debt obligations are based on published market quotations and are classified as Level 1 in the fair value hierarchy. Fair values at March 31, 2026 of the Company’s significant fixed rate debt obligations are as follows:

Principal

Indicated Market

  ​ ​ ​

Amount

  ​ ​ ​

Price

  ​ ​ ​

Fair Value

Senior Notes:

6.625%, due 2027

$

612

100.18

$

613

6.250%, due 2028 (€600 million)

688

100.38

691

5.250%, due 2029 (€500 million)

574

98.87

568

4.750%, due 2030

400

93.24

373

7.250%, due 2031

690

95.68

660

7.375%, due 2032

300

94.48

283

v3.26.1
Contingencies
3 Months Ended
Mar. 31, 2026
Contingencies  
Contingencies

10. Contingencies

The Company has been identified by the U.S. Environmental Protection Agency (“EPA”) or a comparable state or federal agency as a potentially responsible party (“PRP”) at a number of sites in the U.S., including certain Comprehensive Environmental Response, Compensation, and Liability Act of 1980 (“CERCLA”) (Superfund) sites, as well as sites previously owned or operated by the Company.  As an identified PRP, the Company may have liability for investigation, remediation and monitoring of contamination, as well as associated penalties and natural resource damages, if any. The Company has not had monetary sanctions imposed nor has the Company been notified of any potential monetary sanctions at any of the sites.

The Company has recorded aggregate accruals of approximately $21 million, $21 million and $38 million (undiscounted) as of March 31, 2026, December 31, 2025 and March 31, 2025, respectively, for estimated future remediation and monitoring costs at these sites. Although the Company believes its accruals are adequate to cover its portion of future remediation and monitoring costs, there can be no assurance that the ultimate payments will not exceed the amount of the Company’s accruals and will not have a material effect on its results of operations, financial position and cash flows.

As part of the above, from December 31, 1956 through June 1967, the Company, via a wholly-owned subsidiary, owned and operated a paper mill located on the shore of the Cuyahoga River in Ohio, which is now part of the Cuyahoga Valley National Park that is managed by the National Park Service (“NPS”).  The Company and the United States had been engaged in litigation regarding the site in the U.S. District Court for the Northern District of Ohio (Akron), with the United States claiming that the Company should pay $50 million as a remedy for certain soils at the site as well as its past and anticipated future costs. In 2024, the Company recorded charges of $11 million as its best estimate of this liability. In the first quarter of 2025, the Company and the NPS reached a tentative settlement, and the Company recorded a charge of approximately $4 million to Other expense, net in the Condensed Consolidated Results of

Operations to augment its previous accrual balance related to this matter. In the third quarter of 2025, the consent order between the parties was approved by the U.S. District Court, and the Company paid $16.5 million to resolve this matter.

The Company is being investigated by authorities in France for alleged anti-competitive conduct in that country. To date, the French authorities have not officially charged O-I’s business in that country with any violations of competition law. With regard to the above, the Company is committed to compliance with laws in the jurisdictions it operates and maintains policies and procedures regarding competition law.  If the authorities in France find that the Company or any of its subsidiaries or joint ventures violated competition law, they could levy fines, which amounts could be material. At this stage, the Company is unable to predict the ultimate outcome of the investigations, and any potential loss cannot be estimated. 

Other litigation is pending against the Company, in some cases involving ordinary and routine claims incidental to the business of the Company and in others presenting allegations that are non-routine and involve compensatory, punitive or treble damage claims as well as other types of relief. The Company records a liability for such matters when it is both probable that the liability has been incurred and the amount of the liability can be reasonably estimated. Recorded amounts are reviewed and adjusted to reflect changes in the factors upon which the estimates are based, including additional information, negotiations, settlements and other events.

v3.26.1
Share Owners' Equity
3 Months Ended
Mar. 31, 2026
Share Owners' Equity  
Share Owners' Equity

11. Share Owners’ Equity

The activity in share owners’ equity for the three months ended March 31, 2026 and 2025 is as follows:

Share Owners’ Equity of the Company

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

  ​ ​ ​

 

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

Balance on January 1, 2026

$

2

$

3,031

(667)

$

548

$

(1,620)

$

151

$

1,445

Reissuance of common stock (0.2 million shares)

(2)

4

 

2

Shares repurchased (0.6 million shares)

(10)

 

(10)

Stock compensation (0.8 million shares)

5

 

5

Net loss

(73)

2

 

(71)

Other comprehensive income

62

3

 

65

Other

(4)

 

(4)

Balance on March 31, 2026

$

2

$

3,024

$

(667)

$

475

$

(1,558)

$

156

$

1,432

Share Owners’ Equity of the Company

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

  ​ ​ ​

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

  ​ ​ ​

Stock

  ​ ​ ​

Par Value

  ​ ​ ​

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2025

$

2

$

3,053

$

(677)

$

676

$

(1,975)

$

126

$

1,205

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.9 million shares)

(10)

(10)

Stock compensation (1.3 million shares)

4

 

4

Net loss

(16)

4

 

(12)

Other comprehensive income

61

5

 

66

Other

(7)

(7)

Balance on March 31, 2025

$

2

$

3,045

$

(679)

$

660

$

(1,914)

$

135

$

1,249

During the three months ended March 31, 2026, the Company purchased 644,257 shares of its common stock for approximately $10 million. The share purchases were made pursuant to a $100 million anti-dilutive share repurchase program authorized by the Company’s Board of Directors on May 14, 2024, which is intended to offset stock-based compensation provided to the Company’s directors, officers, and employees. Approximately $30 million remained available for purchases under this program as of March 31, 2026.

The Company has 250,000,000 shares of common stock authorized with a par value of $.01 per share. Shares outstanding are as follows:

Shares Outstanding (in thousands)

 

March 31,

December 31,

March 31,

 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

 

Shares of common stock issued (including treasury shares)

 

184,057

183,531

185,824

Treasury shares

 

30,757

30,558

31,141



v3.26.1
Accumulated Other Comprehensive Loss
3 Months Ended
Mar. 31, 2026
Accumulated Other Comprehensive Loss  
Accumulated Other Comprehensive Loss

12. Accumulated Other Comprehensive Loss

The activity in accumulated other comprehensive loss for the three months ended March 31, 2026 and 2025 is as follows:

Total

 

Accumulated

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

 

  ​ ​ ​

Fluctuations

  ​ ​ ​

Instruments

  ​ ​ ​

Benefit Plans

  ​ ​ ​

Loss

 

Balance on January 1, 2026

$

(1,019)

$

(119)

$

(482)

$

(1,620)

Change before reclassifications

 

20

32

(1)

 

51

Amounts reclassified from accumulated other comprehensive income (loss)

3

(a)  

 

6

(b)  

 

9

Translation effect

3

3

Tax effect

(1)

(1)

Other comprehensive income (loss) attributable to the Company

 

20

 

34

 

8

 

62

Balance on March 31, 2026

$

(999)

$

(85)

$

(474)

$

(1,558)

Total

Accumulated

 

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

  ​ ​ ​

Fluctuations

  ​ ​ ​

Instruments

  ​ ​ ​

Benefit Plans

  ​ ​ ​

Loss

 

Balance on January 1, 2025

$

(1,435)

$

(14)

$

(526)

$

(1,975)

 

Change before reclassifications

 

92

(28)

(2)

 

62

Amounts reclassified from accumulated other comprehensive income (loss)

3

(a)  

 

5

(b)  

 

8

Translation effect

(6)

(6)

Tax effect

(3)

(3)

Other comprehensive income (loss) attributable to the Company

 

92

 

(28)

 

(3)

 

61

Balance on March 31, 2025

$

(1,343)

$

(42)

$

(529)

$

(1,914)

(a)Amount is recorded to cost of goods sold and interest expense, net in the Condensed Consolidated Results of Operations (see Note 5 for additional information).
(b)Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost.
v3.26.1
Other Expense, Net
3 Months Ended
Mar. 31, 2026
Other Expense, Net  
Other Expense, Net

13. Other Expense, Net

Other expense, net for the three months ended March 31, 2026 and 2025 included the following:

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Restructuring, asset impairment and other charges

$

(38)

$

(82)

Gain (loss) on sale of joint venture and miscellaneous assets

(46)

6

Legacy environmental charge (see Note 10)

(4)

Intangible amortization expense

(7)

(6)

Foreign currency exchange loss

1

Royalty income

4

5

Other income (expense)

(5)

(1)

Other expense, net

$

(91)

$

(82)

In the first quarter of 2026, the Company recorded pre-tax losses of approximately $46 million, primarily related to the sale of its share of a joint venture in the former Asia Pacific region. In the first quarter of 2025, the Company recorded pre-tax gains of approximately $6 million on the sale of land and buildings of a previously closed plant in the Americas.

v3.26.1
Earnings (Loss) Per Share
3 Months Ended
Mar. 31, 2026
Earnings (Loss) Per Share  
Earnings (Loss) Per Share

14. Earnings (Loss) Per Share

The following table sets forth the computation of basic and diluted earnings (loss) per share for the three months ended March 31, 2026 and 2025:

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

 

  ​ ​ ​

 

  ​ ​ ​

Net loss attributable to the Company

$

(73)

$

(16)

Denominator (in thousands):

Denominator for basic earnings per share-weighted average shares outstanding

 

152,683

153,708

Effect of dilutive securities:

Stock options and other

 

 

Denominator for diluted earnings per share-adjusted weighted average shares outstanding

 

152,683

153,708

Basic earnings (loss) per share:

Net loss attributable to the Company

$

(0.48)

$

(0.10)

Diluted earnings (loss) per share:

Net loss attributable to the Company

$

(0.48)

$

(0.10)

The diluted earnings (loss) per share computation for the three months ended March 31, 2026 and 2025 excludes 522,260 and 703,796 weighted average shares of common stock, respectively, due to their antidilutive effect, which includes unvested restricted stock units and performance vested restricted share units. For the three months ended March 31, 2026 and 2025, diluted earnings (loss) per share of common stock was equal to basic loss per share of common stock due to the net loss attributable to the Company.

v3.26.1
Supplemental Cash Flow Information
3 Months Ended
Mar. 31, 2026
Supplemental Cash Flow Information  
Supplemental Cash Flow Information

15. Supplemental Cash Flow Information

Income taxes paid in cash were as follows:

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

 

U.S.

$

5

$

4

Non-U.S.

 

31

 

39

Total income taxes paid in cash

$

36

$

43

Interest paid in cash for the three months ended March 31, 2026 and 2025 was $49 million and $56 million, respectively.

The Company uses various factoring programs to sell certain trade receivables to financial institutions as part of managing its cash flows. Sales of trade receivables are accounted for in accordance with ASC Topic 860, Transfers and Servicing.  Trade receivables sold under the factoring programs are transferred without recourse to the Company and accounted for as true sales and, therefore, are excluded from Trade receivables, net in the Condensed Consolidated Balance Sheets. At March 31, 2026, December 31, 2025 and March 31, 2025, the total amount of trade receivables sold by the Company was $438 million, $531 million, and $504 million, respectively. These amounts included $167 million, $159 million and $180 million at March 31, 2026, December 31, 2025, and March 31, 2025, respectively, for trade receivable amounts factored under supply-chain financing programs linked to commercial arrangements with key customers. The Company is the master servicer for the factoring programs that are not associated with key customers and is responsible for administering and collecting receivables.

The Company’s use of its accounts receivable factoring programs resulted in an increase to cash utilized in operating activities of approximately $93 million and $31 million for the three months ended March 31, 2026 and March 31, 2025, respectively. For the three months ended March 31, 2026 and 2025, the Company recorded expenses related to these factoring programs of approximately $4 million and $5 million, respectively.

In addition, the Company has agreements with third-party administrators that allow participating vendors to track the Company’s payments and, if voluntarily elected by the vendor, to sell payment obligations from the Company to financial institutions as part of a Supply Chain Financing (“SCF”) Program.

The Company’s outstanding obligations under the SCF Program are as follows:

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Confirmed obligations outstanding at the beginning of the period

$

69

$

82

Invoices confirmed during the period

 

74

 

78

Confirmed invoices paid during the period

(80)

(92)

Confirmed obligations outstanding at the end of the period

$

63

$

68

v3.26.1
Pay vs Performance Disclosure - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Pay vs Performance Disclosure    
Net Income (Loss) $ (73) $ (16)
v3.26.1
Insider Trading Arrangements
3 Months Ended
Mar. 31, 2026
Trading Arrangements, by Individual  
Rule 10b5-1 Arrangement Adopted false
Non-Rule 10b5-1 Arrangement Adopted false
Rule 10b5-1 Arrangement Terminated false
Non-Rule 10b5-1 Arrangement Terminated false
v3.26.1
Segment Information (Tables)
3 Months Ended
Mar. 31, 2026
Segment Information  
Schedule of segment operating profit (loss) for the Company's reportable segments

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Americas

Europe

Total

Americas

Europe

Total

Reportable segment net sales

$

871

$

655

$

1,526

$

873

$

667

$

1,540

Other

14

27

Net Sales

 

 

$

1,540

$

1,567

Less:

Cost of goods sold

706

622

703

558

Selling, administrative, engineering and research and development expenses

36

39

43

46

Equity earnings

(20)

(6)

(19)

(4)

Other segment expenses (income)

7

5

(1)

Segment operating profit

$

142

$

$

142

$

141

$

68

$

209

Items excluded from segment operating profit:

Reconciliation of segment operating profit

Retained corporate costs and other

(32)

(30)

Restructuring, asset impairment and other charges

(38)

(82)

Legacy environmental charge

(4)

Gain (loss) on sale of joint venture and miscellaneous assets

(46)

6

Interest expense, net

(79)

(81)

Earnings (loss) before income taxes

$

(53)

$

18

Schedule of assets, equity investments, equity earnings, capital expenditures and depreciation and amortization expense for the Company's reportable segments

As of March 31,

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Reportable

  ​ ​ ​

Retained

  ​ ​ ​

Consoli-

 

Segment

Corp Costs

dated

 

Americas

Europe

Totals

and Other

Totals

 

Total assets:

2026

$

4,757

$

3,873

$

8,630

$

320

$

8,950

2025

4,707

3,682

8,389

340

8,729

Equity investments:

2026

$

474

$

213

$

687

$

33

$

720

2025

456

193

649

34

683

Three months ended March 31,

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Reportable

  ​ ​ ​

Retained

  ​ ​ ​

Consoli-

Segment

Corp Costs

dated

Americas

Europe

Totals

and Other

Totals

Equity earnings:

2026

$

20

$

6

$

26

$

$

26

2025

19

4

23

23

Capital expenditures:

2026

$

65

$

76

$

141

$

1

$

142

2025

62

72

134

1

135

Depreciation and amortization expense:

2026

$

71

$

42

$

113

$

3

$

116

2025

73

37

110

5

115

Total assets for the Company's reportable segments

As of March 31,

  ​ ​ ​

U.S.

  ​ ​ ​

Non-U.S.

  ​ ​ ​

Total

 

2026

$

774

$

2,829

$

3,603

2025

 

897

2,689

3,586

Schedule of segment information by geographic segment

Three months ended March 31,

  ​ ​ ​

U.S.

  ​ ​ ​

Non-U.S.

  ​ ​ ​

Total

 

2026

$

407

$

1,133

$

1,540

2025

 

441

1,126

1,567

v3.26.1
Revenue (Tables)
3 Months Ended
Mar. 31, 2026
Revenue  
Schedule of disaggregation of revenue by customer end use

Three months ended March 31, 2026

  ​ ​ ​

Americas

Europe

Total

Alcoholic beverages (beer, wine, spirits)

 

$

465

 

$

464

 

$

929

Food and other

 

239

118

 

357

Non-alcoholic beverages

 

167

73

 

240

Reportable segment totals

$

871

$

655

$

1,526

Other

 

14

Net sales

 

$

1,540

v3.26.1
Inventories (Tables)
3 Months Ended
Mar. 31, 2026
Inventories  
Schedule of major classes of inventory

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Finished goods

$

805

$

781

$

747

Raw materials

 

157

 

182

 

188

Operating supplies

 

41

 

39

 

50

$

1,003

$

1,002

$

985

v3.26.1
Derivative Instruments (Tables)
3 Months Ended
Mar. 31, 2026
Derivative Instruments  
Balance Sheet Classification of derivative instruments

Fair Value of

Fair Value of

Hedge Assets

Hedge Liabilities

March 31,

December 31,

March 31,

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Derivatives designated as hedging instruments:

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Commodity forward contracts and collars (a)

$

19

$

$

1

$

2

$

2

$

2

Fair value hedges of foreign exchange risk (b)

2

1

3

64

78

90

Net investment hedges (c)

11

11

11

174

207

73

Total derivatives accounted for as hedges

$

32

$

12

$

15

$

240

$

287

$

165

Derivatives not designated as hedges:

Foreign exchange derivative contracts (d)

5

2

10

6

13

Total derivatives

$

37

$

14

$

25

$

246

$

287

$

178

Current

$

22

$

14

$

25

$

67

$

71

$

60

Noncurrent

15

-

179

216

118

Total derivatives

$

37

$

14

$

25

$

246

$

287

$

178

(a)The notional amount of the commodity forward contracts and collars was approximately 25 million, 9 million, and 8 million British Thermal Units at March 31, 2026, December 31, 2025, and March 31, 2025, respectively. The maximum maturity dates are in 2027 at March 31, 2026, December 31, 2025, and March 31, 2025.
(b)The notional amounts of the fair value hedges of foreign exchange risk were $400 million at March 31, 2026, $400 million at December 31, 2025 and $816 million at March 31, 2025. The maximum maturity dates are in 2030 at March 31, 2026, December 31, 2025 and March 31, 2025.
(c)The notional amounts of the net investment hedges were €1,176 million at March 31, 2026, €1,176 million at December 31, 2025 and €969 million at March 31, 2025. The maximum maturity dates are in 2028 at March 31, 2026 and December 31, 2025 and in 2026 at March 31, 2025.
(d)The notional amounts of the foreign exchange derivative contracts were $677 million, $526 million and $957 million at March 31, 2026, December 31, 2025 and March 31, 2025, respectively. The maximum maturity dates are in 2026 at March 31, 2026 and December 31, 2025 and at March 31, 2025.

Effects of derivative instruments on the results of operations

v3.26.1
Restructuring Accruals (Tables)
3 Months Ended
Mar. 31, 2026
Restructuring Accruals  
Selected information related to the restructuring accruals

Fit to Win program

Employee

Asset

Other

Total

  ​ ​ ​

Costs

Impairment

Exit Costs

  ​ ​ ​

Restructuring

Balance at January 1, 2026

$

113

$

$

70

$

183

Charges

27

11

38

Net cash paid, principally severance and related benefits

 

(25)

(10)

 

(35)

Other, including foreign exchange translation

 

(2)

(3)

 

(5)

Balance at March 31, 2026

$

113

$

$

68

$

181

Fit to Win program

Other Restructuring

Employee

Asset

Other

Employee

Asset

Other

Total

Costs

Impairment

Exit Costs

Costs

Impairment

Exit Costs

Restructuring

Balance at January 1, 2025

$

51

$

$

18

$

7

$

$

4

$

80

Charges

50

14

18

82

Write-down of assets to net realizable value

(14)

(14)

Net cash paid, principally severance and related benefits

 

(23)

(4)

 

(1)

 

(28)

Balance at March 31, 2025

$

78

$

$

32

$

6

$

$

4

$

120

v3.26.1
Pension Benefit Plans (Tables)
3 Months Ended
Mar. 31, 2026
Pension Benefit Plans.  
Defined Benefit Plans and Other Postretirement Benefit Plans  
Components of net periodic pension cost

U.S.

Non-U.S.

 

Three months ended March 31,

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2026

  ​ ​ ​

2025

 

Service cost

$

1

$

1

$

2

$

2

Interest cost

 

10

 

11

 

9

 

9

Expected asset return

(12)

(13)

(7)

(8)

Amortization of actuarial loss

3

3

3

2

Net periodic pension cost

$

2

$

2

$

7

$

5

v3.26.1
Debt (Tables)
3 Months Ended
Mar. 31, 2026
Debt  
Long-term Debt

March 31,

December 31,

March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

Secured Credit Agreement:

Revolving Credit Facility:

Revolving Loans

$

$

$

Term Loans:

Term Loans A

792

799

Term Loans B

642

643

Previous Secured Credit Agreement:

Revolving Credit Facility:

Revolving Loans

185

Term Loans:

Term Loans A

1,338

Senior Notes:

6.625%, due 2027

611

610

609

6.250%, due 2028 (€600 million)

684

700

645

5.250%, due 2029 (€500 million)

568

581

535

4.750%, due 2030

398

397

397

7.250%, due 2031

684

684

683

7.375%, due 2032

297

297

296

Finance leases

161

174

192

Other

 

27

18

9

Total long-term debt

 

4,864

 

4,903

4,889

Less amounts due within one year

 

64

66

103

Long-term debt

$

4,800

$

4,837

$

4,786

Fair values of the Company's significant fixed rate debt obligations

Principal

Indicated Market

  ​ ​ ​

Amount

  ​ ​ ​

Price

  ​ ​ ​

Fair Value

Senior Notes:

6.625%, due 2027

$

612

100.18

$

613

6.250%, due 2028 (€600 million)

688

100.38

691

5.250%, due 2029 (€500 million)

574

98.87

568

4.750%, due 2030

400

93.24

373

7.250%, due 2031

690

95.68

660

7.375%, due 2032

300

94.48

283

v3.26.1
Share Owners' Equity (Tables)
3 Months Ended
Mar. 31, 2026
Share Owners' Equity  
Activity in share owner's equity

Share Owners’ Equity of the Company

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

  ​ ​ ​

 

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

Stock

Par Value

Stock

Earnings

Loss

Interests

Equity

Balance on January 1, 2026

$

2

$

3,031

(667)

$

548

$

(1,620)

$

151

$

1,445

Reissuance of common stock (0.2 million shares)

(2)

4

 

2

Shares repurchased (0.6 million shares)

(10)

 

(10)

Stock compensation (0.8 million shares)

5

 

5

Net loss

(73)

2

 

(71)

Other comprehensive income

62

3

 

65

Other

(4)

 

(4)

Balance on March 31, 2026

$

2

$

3,024

$

(667)

$

475

$

(1,558)

$

156

$

1,432

Share Owners’ Equity of the Company

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

  ​ ​ ​

Accumulated

  ​ ​ ​

  ​ ​ ​

Capital in

Other

Non-

Total Share

Common

Excess of

Treasury

Retained

Comprehensive

controlling

Owners' 

  ​ ​ ​

Stock

  ​ ​ ​

Par Value

  ​ ​ ​

Stock

Earnings

Loss

Interests

Equity

 

Balance on January 1, 2025

$

2

$

3,053

$

(677)

$

676

$

(1,975)

$

126

$

1,205

Reissuance of common stock (0.2 million shares)

(2)

5

 

3

Shares repurchased (0.9 million shares)

(10)

(10)

Stock compensation (1.3 million shares)

4

 

4

Net loss

(16)

4

 

(12)

Other comprehensive income

61

5

 

66

Other

(7)

(7)

Balance on March 31, 2025

$

2

$

3,045

$

(679)

$

660

$

(1,914)

$

135

$

1,249

Schedule of shares outstanding

Shares Outstanding (in thousands)

 

March 31,

December 31,

March 31,

 

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

2025

 

Shares of common stock issued (including treasury shares)

 

184,057

183,531

185,824

Treasury shares

 

30,757

30,558

31,141

v3.26.1
Accumulated Other Comprehensive Loss (Tables)
3 Months Ended
Mar. 31, 2026
Accumulated Other Comprehensive Loss  
Component of accumulated other comprehensive income (loss)

The activity in accumulated other comprehensive loss for the three months ended March 31, 2026 and 2025 is as follows:

Total

 

Accumulated

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

 

  ​ ​ ​

Fluctuations

  ​ ​ ​

Instruments

  ​ ​ ​

Benefit Plans

  ​ ​ ​

Loss

 

Balance on January 1, 2026

$

(1,019)

$

(119)

$

(482)

$

(1,620)

Change before reclassifications

 

20

32

(1)

 

51

Amounts reclassified from accumulated other comprehensive income (loss)

3

(a)  

 

6

(b)  

 

9

Translation effect

3

3

Tax effect

(1)

(1)

Other comprehensive income (loss) attributable to the Company

 

20

 

34

 

8

 

62

Balance on March 31, 2026

$

(999)

$

(85)

$

(474)

$

(1,558)

Total

Accumulated

 

Net Effect of

Change in Certain

Other

Exchange Rate

Derivative

Employee

Comprehensive

  ​ ​ ​

Fluctuations

  ​ ​ ​

Instruments

  ​ ​ ​

Benefit Plans

  ​ ​ ​

Loss

 

Balance on January 1, 2025

$

(1,435)

$

(14)

$

(526)

$

(1,975)

 

Change before reclassifications

 

92

(28)

(2)

 

62

Amounts reclassified from accumulated other comprehensive income (loss)

3

(a)  

 

5

(b)  

 

8

Translation effect

(6)

(6)

Tax effect

(3)

(3)

Other comprehensive income (loss) attributable to the Company

 

92

 

(28)

 

(3)

 

61

Balance on March 31, 2025

$

(1,343)

$

(42)

$

(529)

$

(1,914)

(a)Amount is recorded to cost of goods sold and interest expense, net in the Condensed Consolidated Results of Operations (see Note 5 for additional information).
(b)Amount is included in the computation of net periodic pension cost (see Note 7 for additional information) and net post-retirement benefit cost.
v3.26.1
Other Expense, Net (Tables)
3 Months Ended
Mar. 31, 2026
Other Expense, Net  
Schedule of other income (expense), net

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Restructuring, asset impairment and other charges

$

(38)

$

(82)

Gain (loss) on sale of joint venture and miscellaneous assets

(46)

6

Legacy environmental charge (see Note 10)

(4)

Intangible amortization expense

(7)

(6)

Foreign currency exchange loss

1

Royalty income

4

5

Other income (expense)

(5)

(1)

Other expense, net

$

(91)

$

(82)

v3.26.1
Earnings (Loss) Per Share (Tables)
3 Months Ended
Mar. 31, 2026
Earnings (Loss) Per Share  
Computation of basic and diluted earnings per share

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

Numerator:

 

  ​ ​ ​

 

  ​ ​ ​

Net loss attributable to the Company

$

(73)

$

(16)

Denominator (in thousands):

Denominator for basic earnings per share-weighted average shares outstanding

 

152,683

153,708

Effect of dilutive securities:

Stock options and other

 

 

Denominator for diluted earnings per share-adjusted weighted average shares outstanding

 

152,683

153,708

Basic earnings (loss) per share:

Net loss attributable to the Company

$

(0.48)

$

(0.10)

Diluted earnings (loss) per share:

Net loss attributable to the Company

$

(0.48)

$

(0.10)

v3.26.1
Supplemental Cash Flow Information (Tables)
3 Months Ended
Mar. 31, 2026
Supplemental Cash Flow Information  
Schedule of activity and ending balances of the Company's supplier finance programs

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

  ​ ​ ​

Confirmed obligations outstanding at the beginning of the period

$

69

$

82

Invoices confirmed during the period

 

74

 

78

Confirmed invoices paid during the period

(80)

(92)

Confirmed obligations outstanding at the end of the period

$

63

$

68

Income taxes paid (received) in cash

Three months ended March 31,

  ​ ​ ​

2026

  ​ ​ ​

2025

 

U.S.

$

5

$

4

Non-U.S.

 

31

 

39

Total income taxes paid in cash

$

36

$

43

v3.26.1
Segment Information (Details)
3 Months Ended
Mar. 31, 2026
segment
Segment Information  
Number of reportable segments 2
Number of operating segments 2
v3.26.1
Segment Information - Segment Operating Profits and Reporting Segments Totals (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment operating profit:    
Net sales $ 1,540 $ 1,567
Cost of goods sold (1,341) (1,287)
Selling and administrative expense (99) (109)
Equity earnings (26) (23)
Segment operating profit 142 209
Items excluded from segment operating profit:    
Retained corporate costs and other (32) (30)
Restructuring, asset impairment and other charges (38) (82)
Legacy environmental charge   (4)
Gain (loss) on sale of joint venture and miscellaneous assets (46) 6
Interest expense, net (79) (81)
Earnings (loss) before income taxes (53) 18
Reportable segment totals    
Segment operating profit:    
Net sales 1,526 1,540
Equity earnings (26) (23)
Other    
Segment operating profit:    
Net sales 14 27
Americas    
Segment operating profit:    
Cost of goods sold 706 703
Selling and administrative expense 36 43
Equity earnings (20) (19)
Other segment expenses (income) 7 5
Segment operating profit 142 141
Americas | Reportable segment totals    
Segment operating profit:    
Net sales 871 873
Equity earnings (20) (19)
Europe    
Segment operating profit:    
Cost of goods sold 622 558
Selling and administrative expense 39 46
Equity earnings (6) (4)
Other segment expenses (income)   (1)
Segment operating profit   68
Europe | Reportable segment totals    
Segment operating profit:    
Net sales 655 667
Equity earnings $ (6) $ (4)
v3.26.1
Segment Information - Total Assets and Equity Investments (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Assets      
Total assets $ 8,950 $ 9,243 $ 8,729
Equity investments      
Equity investments 720   683
Reportable segment totals      
Assets      
Total assets 8,630   8,389
Equity investments      
Equity investments 687   649
Retained Corp Costs and Other      
Assets      
Total assets 320   340
Equity investments      
Equity investments 33   34
Americas | Reportable segment totals      
Assets      
Total assets 4,757   4,707
Equity investments      
Equity investments 474   456
Europe | Reportable segment totals      
Assets      
Total assets 3,873   3,682
Equity investments      
Equity investments $ 213   $ 193
v3.26.1
Segment Information - Equity Earnings, Capital Expenditures and Depreciation and Amortization Expense (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Equity earnings:    
Equity earnings $ 26 $ 23
Capital expenditures:    
Capital expenditures: 142 135
Depreciation and amortization expense:    
Depreciation and amortization 116 115
Reportable segment totals    
Equity earnings:    
Equity earnings 26 23
Capital expenditures:    
Capital expenditures: 141 134
Depreciation and amortization expense:    
Depreciation and amortization 113 110
Retained Corp Costs and Other    
Capital expenditures:    
Capital expenditures: 1 1
Depreciation and amortization expense:    
Depreciation and amortization 3 5
Americas    
Equity earnings:    
Equity earnings 20 19
Americas | Reportable segment totals    
Equity earnings:    
Equity earnings 20 19
Capital expenditures:    
Capital expenditures: 65 62
Depreciation and amortization expense:    
Depreciation and amortization 71 73
Europe    
Equity earnings:    
Equity earnings 6 4
Europe | Reportable segment totals    
Equity earnings:    
Equity earnings 6 4
Capital expenditures:    
Capital expenditures: 76 72
Depreciation and amortization expense:    
Depreciation and amortization $ 42 $ 37
v3.26.1
Segment Information - Tangible long-lived assets, including property, plant and equipment and operating lease right-of-use assets, by geographic region (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Mar. 31, 2025
Long-Lived Assets    
Tangible long lived assets, including property, plant and equipment and operating lease right-of-use assets $ 3,603 $ 3,586
U.S.    
Long-Lived Assets    
Tangible long lived assets, including property, plant and equipment and operating lease right-of-use assets 774 897
Non-U.S.    
Long-Lived Assets    
Tangible long lived assets, including property, plant and equipment and operating lease right-of-use assets $ 2,829 $ 2,689
v3.26.1
Segment Information - Net sales by geographic region (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Segment Reporting Information    
Net sales $ 1,540 $ 1,567
U.S.    
Segment Reporting Information    
Net sales 407 441
Non-U.S.    
Segment Reporting Information    
Net sales $ 1,133 $ 1,126
France    
Segment Reporting Information    
Percentage of consolidated net sales outside of the U.S. 12.00% 14.00%
Italy    
Segment Reporting Information    
Percentage of consolidated net sales outside of the U.S. 12.00% 12.00%
Mexico    
Segment Reporting Information    
Percentage of consolidated net sales outside of the U.S. 13.00% 13.00%
v3.26.1
Revenue (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Disaggregation of Revenue    
Net sales $ 1,540 $ 1,567
Reportable Segment Totals    
Disaggregation of Revenue    
Net sales 1,526 1,540
Americas    
Disaggregation of Revenue    
Net sales 871 873
Europe    
Disaggregation of Revenue    
Net sales 655 667
Other    
Disaggregation of Revenue    
Net sales 14 27
Alcoholic beverages (beer, wine, spirits)    
Disaggregation of Revenue    
Net sales 929 984
Alcoholic beverages (beer, wine, spirits) | Americas    
Disaggregation of Revenue    
Net sales 465 503
Alcoholic beverages (beer, wine, spirits) | Europe    
Disaggregation of Revenue    
Net sales 464 481
Food and other    
Disaggregation of Revenue    
Net sales 357 328
Food and other | Americas    
Disaggregation of Revenue    
Net sales 239 217
Food and other | Europe    
Disaggregation of Revenue    
Net sales 118 111
Non-alcoholic beverages    
Disaggregation of Revenue    
Net sales 240 228
Non-alcoholic beverages | Americas    
Disaggregation of Revenue    
Net sales 167 153
Non-alcoholic beverages | Europe    
Disaggregation of Revenue    
Net sales $ 73 $ 75
v3.26.1
Credit Losses (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Credit Losses      
Accounts receivable, net $ 805 $ 601 $ 758
Allowance for doubtful accounts $ 32 $ 31 $ 32
v3.26.1
Inventories (Details) - USD ($)
$ in Millions
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Inventories      
Finished goods $ 805 $ 781 $ 747
Raw materials 157 182 188
Operating supplies 41 39 50
Inventories $ 1,003 $ 1,002 $ 985
v3.26.1
Derivative Instruments - Derivatives and Hedges (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Commodity forward contracts and collars | Cash Flow Hedges      
Derivatives and Hedges      
Unrecognized gain (loss) included in Accumulated OCI $ (7) $ 1 $ 0
Foreign exchange risk | Cash Flow Hedges      
Derivatives and Hedges      
Unrecognized gain (loss) included in Accumulated OCI 0 0 0
Foreign exchange risk | Fair Value Hedges      
Derivatives and Hedges      
Amount excluded from assessment of effectiveness and included in Accumulated OCI $ 5 $ 2 $ 1
v3.26.1
Derivative Instruments - Balance Sheet Classification (Details)
€ in Millions, $ / BTU in Millions, $ in Millions
3 Months Ended 12 Months Ended
Mar. 31, 2026
USD ($)
$ / BTU
Mar. 31, 2025
USD ($)
$ / BTU
Dec. 31, 2025
USD ($)
$ / BTU
Mar. 31, 2026
EUR (€)
Dec. 31, 2025
EUR (€)
Mar. 31, 2025
EUR (€)
Derivatives, Fair Value            
Total asset derivatives $ 37 $ 25 $ 14      
Total liability derivatives 246 178 287      
Current derivative asset 22 25 14      
Current derivative liability 67 60 71      
Noncurrent derivative asset 15          
Noncurrent derivative liability 179 118 216      
Derivatives designated as hedging instruments            
Derivatives, Fair Value            
Total asset derivatives 32 15 12      
Total liability derivatives $ 240 $ 165 $ 287      
Derivatives designated as hedging instruments | Commodity forward contracts and collars            
Derivatives, Fair Value            
British Thermal Units ("BTUs") | $ / BTU 25 8 9      
Total asset derivatives $ 19 $ 1        
Total liability derivatives 2 2 $ 2      
Derivatives designated as hedging instruments | Foreign exchange risk            
Derivatives, Fair Value            
Notional amount 400 816 400      
Total asset derivatives 2 3 1      
Total liability derivatives 64 90 78      
Derivatives designated as hedging instruments | Net investment hedges            
Derivatives, Fair Value            
Notional amount | €       € 1,176 € 1,176 € 969
Total asset derivatives 11 11 11      
Total liability derivatives 174 73 207      
Derivatives not designated as hedging instruments | Foreign exchange contracts            
Derivatives, Fair Value            
Notional amount 677 957 526      
Total asset derivatives 5 10 $ 2      
Total liability derivatives $ 6 $ 13        
v3.26.1
Derivative Instruments - Effects of Derivative Instruments (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Derivatives not designated as hedging instruments | Foreign exchange contracts    
Derivatives and Hedges    
Amount of Loss Recognized in Other income (expense), net $ (4) $ 5
Derivatives designated as hedging instruments    
Derivatives and Hedges    
Gain (Loss) Recognized in OCI (Effective Portion) 35 (31)
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) 3 3
Derivatives designated as hedging instruments | Net Investment Hedges | Interest expense, net    
Derivatives and Hedges    
Gain (Loss) Recognized in OCI (Effective Portion) 36 (37)
Gain (Loss) Reclassified from Accumulated OCI into Income (Effective Portion) 3 3
Derivatives designated as hedging instruments | Commodity forward contracts and collars | Cash Flow Hedges | Cost of goods sold    
Derivatives and Hedges    
Gain (Loss) Recognized in OCI (Effective Portion) $ (1) $ 6
v3.26.1
Restructuring (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Restructuring accrual    
Beginning balance, restructuring reserve $ 183 $ 80
Charges 38 82
Write-down of assets to net realizable value   (14)
Net cash paid, principally severance and related benefits (35) (28)
Other, including foreign exchange translation (5)  
Ending balance, restructuring reserve 181 120
Restructuring, Additional Information    
Carrying value of impaired assets 0  
Americas    
Restructuring accrual    
Charges 3 6
Europe    
Restructuring accrual    
Charges 31 52
Other    
Restructuring accrual    
Charges 4 24
Fit to Win Initiative | Other    
Restructuring, Additional Information    
Cumulative charges 684 283
Fit to Win Initiative | Employee Costs    
Restructuring accrual    
Beginning balance, restructuring reserve 113 51
Charges 27 50
Net cash paid, principally severance and related benefits (25) (23)
Other, including foreign exchange translation (2)  
Ending balance, restructuring reserve 113 78
Fit to Win Initiative | Asset Impairment    
Restructuring accrual    
Charges   14
Write-down of assets to net realizable value   (14)
Fit to Win Initiative | Other Exit Costs    
Restructuring accrual    
Beginning balance, restructuring reserve 70 18
Charges 11 18
Net cash paid, principally severance and related benefits (10) (4)
Other, including foreign exchange translation (3)  
Ending balance, restructuring reserve $ 68 32
Other Restructuring | Employee Costs    
Restructuring accrual    
Beginning balance, restructuring reserve   7
Net cash paid, principally severance and related benefits   (1)
Ending balance, restructuring reserve   6
Other Restructuring | Other Exit Costs    
Restructuring accrual    
Beginning balance, restructuring reserve   4
Ending balance, restructuring reserve   $ 4
v3.26.1
Pension Benefit Plans (Details) - Pension Benefit Plans. - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
U.S.    
Components of net periodic pension cost    
Service cost $ 1 $ 1
Interest cost $ 10 $ 11
Defined Benefit Plan, Net Periodic Benefit Cost (Credit), Interest Cost, Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Expected asset return $ (12) $ (13)
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Expected Return (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Amortization of actuarial loss $ 3 $ 3
Defined Benefit Plan, Net Periodic Benefit (Cost) Credit, Amortization of Gain (Loss), Statement of Income or Comprehensive Income [Extensible Enumeration] Other Operating Income (Expense), Net Other Operating Income (Expense), Net
Net periodic pension cost $ 2 $ 2
Non-U.S.    
Components of net periodic pension cost    
Service cost 2 2
Interest cost 9 9
Expected asset return (7) (8)
Amortization of actuarial loss 3 2
Net periodic pension cost $ 7 $ 5
v3.26.1
Income Taxes (Details)
3 Months Ended
Mar. 31, 2026
Income Taxes.  
Statutory U.S. Federal tax rate (as a percent) 21.00%
v3.26.1
Debt (Details)
$ / shares in Units, € in Millions, $ in Millions
3 Months Ended
Mar. 31, 2026
USD ($)
agreement
$ / shares
Mar. 31, 2026
EUR (€)
Dec. 31, 2025
USD ($)
Dec. 31, 2025
EUR (€)
Mar. 31, 2025
USD ($)
Mar. 31, 2025
EUR (€)
Mar. 25, 2022
USD ($)
Debt Instrument              
Total long-term debt $ 4,864   $ 4,903   $ 4,889    
Less amounts due within one year 64   66   103    
Long-term debt 4,800   4,837   4,786    
Maximum Borrowing Capacity             $ 2,700
Secured Credit Agreement              
Debt Instrument              
Unused Credit $ 1,240            
Number of financial maintenance covenants | agreement 1            
Additional default interest rate per annum applied to all obligations owed under the Agreement 2.00%            
Leverage Ratio 2.5            
Secured Credit Agreement | Minimum              
Debt Instrument              
Interest rate margin, Term SOFR and Euro currency rate loans 1.00% 1.00%          
Interest rate margin, Base Rate loans (as a percent) 0.00%            
Facility fee payable (as a percent) 0.20%            
Secured Credit Agreement | Maximum              
Debt Instrument              
Interest rate margin, Term SOFR and Euro currency rate loans 1.75% 1.75%          
Interest rate margin, Base Rate loans (as a percent) 0.75%            
Facility fee payable (as a percent) 0.35%            
Revolving Loans              
Debt Instrument              
Total long-term debt         185    
Term Loans A              
Debt Instrument              
Total long-term debt $ 792   799        
Maximum Borrowing Capacity 800            
Term Loans B              
Debt Instrument              
Total long-term debt $ 642   643        
Interest rate margin, Term SOFR rate loans 3.00% 3.00%          
Maximum Borrowing Capacity $ 650            
Term Loans A              
Debt Instrument              
Total long-term debt         1,338    
Senior Notes 6.625%, due 2027              
Debt Instrument              
Total long-term debt $ 611   610   609    
Interest rate, stated percentage 6.625% 6.625%          
Fair values of fixed rate debt obligations              
Principal Amount $ 612            
Indicated Market Price (in dollars per share) | $ / shares $ 100.18            
Fair Value $ 613            
Senior Notes 6.250%, due 2028 (€600 million)              
Debt Instrument              
Total long-term debt $ 684 € 600 700 € 600 645 € 600  
Interest rate, stated percentage 6.25% 6.25%          
Fair values of fixed rate debt obligations              
Principal Amount $ 688            
Indicated Market Price (in dollars per share) | $ / shares $ 100.38            
Fair Value $ 691            
Senior Notes 5.250%, due 2029 (€500 million)              
Debt Instrument              
Total long-term debt $ 568 € 500 581 € 500 535 € 500  
Interest rate, stated percentage 5.25% 5.25%          
Fair values of fixed rate debt obligations              
Principal Amount $ 574            
Indicated Market Price (in dollars per share) | $ / shares $ 98.87            
Fair Value $ 568            
Senior Notes 4.750%, due 2030              
Debt Instrument              
Total long-term debt $ 398   397   397    
Interest rate, stated percentage 4.75% 4.75%          
Fair values of fixed rate debt obligations              
Principal Amount $ 400            
Indicated Market Price (in dollars per share) | $ / shares $ 93.24            
Fair Value $ 373            
Senior Notes 7.250% due 2031              
Debt Instrument              
Total long-term debt $ 684   684   683    
Interest rate, stated percentage 7.25% 7.25%          
Fair values of fixed rate debt obligations              
Principal Amount $ 690            
Indicated Market Price (in dollars per share) | $ / shares $ 95.68            
Fair Value $ 660            
Senior Notes 7.375% due 2032              
Debt Instrument              
Total long-term debt $ 297   297   296    
Interest rate, stated percentage 7.375% 7.375%          
Fair values of fixed rate debt obligations              
Principal Amount $ 300            
Indicated Market Price (in dollars per share) | $ / shares $ 94.48            
Fair Value $ 283            
Finance leases              
Debt Instrument              
Total long-term debt 161   174   192    
Other debt              
Debt Instrument              
Total long-term debt 27   $ 18   $ 9    
Multicurrency Revolving Credit Facility              
Debt Instrument              
Maximum Borrowing Capacity $ 1,250            
Weighted average interest rate (as a percent) 5.36% 5.36%          
v3.26.1
Contingencies (Details) - USD ($)
$ in Millions
3 Months Ended 12 Months Ended
Sep. 30, 2025
Mar. 31, 2025
Dec. 31, 2024
Mar. 31, 2026
Dec. 31, 2025
Superfund sites          
Other Matters          
Loss contingency accrual   $ 38.0   $ 21.0 $ 21.0
Cuyahoga Valley National Park          
Other Matters          
Payments for legal settlements     $ 11.0    
Anticipated future costs   50.0      
Cuyahoga Valley National Park | Other Expense          
Other Matters          
Litigation settlement charge $ 16.5 $ 4.0      
v3.26.1
Share Owners' Equity - Rollforward (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) $ 1,445 $ 1,205
Reissuance of common stock 2 3
Shares repurchased (10) (10)
Stock compensation 5 4
Net loss (71) (12)
Other comprehensive income 65 66
Other (4) (7)
Balance (Ending) 1,432 1,249
Common Stock    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) 2 2
Balance (Ending) 2 2
Capital in Excess of Par Value    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) 3,031 3,053
Reissuance of common stock (2) (2)
Shares repurchased (10) (10)
Stock compensation 5 4
Balance (Ending) 3,024 3,045
Treasury Stock    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) (667) (677)
Reissuance of common stock 4 5
Other (4) (7)
Balance (Ending) (667) (679)
Retained Earnings    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) 548 676
Net loss (73) (16)
Balance (Ending) 475 660
Accumulated Other Comprehensive Loss    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) (1,620) (1,975)
Other comprehensive income 62 61
Balance (Ending) (1,558) (1,914)
Non-Controlling Interests    
Increase (Decrease) in Share Owners' Equity    
Balance (Beginning) 151 126
Net loss 2 4
Other comprehensive income 3 5
Balance (Ending) $ 156 $ 135
v3.26.1
Share Owners' Equity - Rollforward Shares (Details) - shares
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Share Owners' Equity    
Reissuance of common stock (in shares) 200,000 200,000
Shares repurchased (in shares) 644,257 900,000
Stock compensation (in shares) 800,000 1,300,000
v3.26.1
Share Owners' Equity - Share Repurchase (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
May 14, 2024
Share Owners' Equity      
Shares repurchased $ 10 $ 10  
Shares repurchased (in shares) 644,257 900,000  
Stock repurchase plan authorized     $ 100
Remaining repurchase of common stock available $ 30    
v3.26.1
Share Owners' Equity - Authorization of Common Stock (Details) - $ / shares
Mar. 31, 2026
Dec. 31, 2025
Mar. 31, 2025
Authorization of common stock      
Shares of common stock authorized 250,000,000 250,000,000 250,000,000
Common stock, par value (in dollars per share) $ 0.01 $ 0.01 $ 0.01
Shares of common stock issued (including treasury shares) 184,057,000 183,531,000 185,824,000
Treasury shares 30,757,000 30,558,000 31,141,000
v3.26.1
Accumulated Other Comprehensive Loss (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax    
Balance (Beginning) $ 1,445 $ 1,205
Other comprehensive income 65 66
Balance (Ending) 1,432 1,249
Net Effect of Exchange Rate Fluctuations    
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax    
Balance (Beginning) (1,019) (1,435)
Change before reclassifications 20 92
Other comprehensive income 20 92
Balance (Ending) (999) (1,343)
Change in Certain Derivative Instruments    
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax    
Balance (Beginning) (119) (14)
Change before reclassifications 32 (28)
Amounts reclassified from accumulated other comprehensive income (loss) 3 3
Tax effect (1) (3)
Other comprehensive income 34 (28)
Balance (Ending) (85) (42)
Employee Benefit Plans    
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax    
Balance (Beginning) (482) (526)
Change before reclassifications (1) (2)
Amounts reclassified from accumulated other comprehensive income (loss) 6 5
Translation effect 3 (6)
Other comprehensive income 8 (3)
Balance (Ending) (474) (529)
Accumulated Other Comprehensive Loss    
Increase (Decrease) Accumulated Other Comprehensive Loss, Net of Tax    
Balance (Beginning) (1,620) (1,975)
Change before reclassifications 51 62
Amounts reclassified from accumulated other comprehensive income (loss) 9 8
Translation effect 3 (6)
Tax effect (1) (3)
Other comprehensive income 62 61
Balance (Ending) $ (1,558) $ (1,914)
v3.26.1
Other Expense, Net (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Other Expense, Net    
Restructuring, asset impairment and other charges $ (38) $ (82)
Gain (loss) on sale of joint venture and miscellaneous assets (46) 6
Legacy environmental charge (see Note 10)   (4)
Intangible amortization expense (7) (6)
Foreign currency exchange loss 1  
Royalty income 4 5
Other income (expense) (5) (1)
Other expense, net $ (91) $ (82)
v3.26.1
Earnings (Loss) Per Share (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Numerator:    
Net loss attributable to the Company $ (73) $ (16)
Denominator (in thousands):    
Denominator for basic earnings per share-weighted average shares outstanding 152,683,000 153,708,000
Effect of dilutive securities:    
Denominator for diluted earnings per share-adjusted weighted average shares outstanding 152,683,000 153,708,000
Basic earnings (loss) per share:    
Net loss attributable to the Company (in dollars per share) $ (0.48) $ (0.1)
Diluted earnings (loss) per share:    
Net loss attributable to the Company (in dollars per share) $ (0.48) $ (0.1)
Weighted average shares of common stock attributable to options not included in diluted earnings per share (in shares) 522,260 703,796
v3.26.1
Supplemental Cash Flow Information (Details) - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Dec. 31, 2025
Dec. 31, 2024
Supplemental Cash Flow Information        
Amount of receivables sold $ 438 $ 504 $ 531  
Receivables sold under supply chain factoring program 167 180 159  
Interest paid in cash 49 56    
Increase or decrease to cash from operating activities from factoring programs (93) (31)    
Expense due to factoring program 4 5    
Income taxes paid in cash        
Income taxes paid in cash 36 43    
Supply Chain Financing        
Supplemental Cash Flow Information        
Outstanding payment obligations to the financial institutions as part of SCF Programs 63 68 $ 69 $ 82
U.S.        
Income taxes paid in cash        
Income taxes paid in cash 5 4    
Non-U.S.        
Income taxes paid in cash        
Income taxes paid in cash $ 31 $ 39    
v3.26.1
Supplemental Cash Flow Information - Company's supplier finance programs (Details) - Supply Chain Financing - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Supplier Finance Program Obligation Roll Forward    
Confirmed obligations outstanding at the beginning of the period $ 69 $ 82
Invoices confirmed during the period 74 78
Confirmed invoices paid during the period (80) (92)
Confirmed obligations outstanding at the end of the period $ 63 $ 68